专利检索 ap:("ALZA CORPORATION") AND inv:"HWANG, Stephen" 第 1 页

1.

发明公开
COMPOSITIONS AND DOSAGE FORMS FOR ENHANCED ABSORPTION OF 3-AMINO-N-BUTYL-PHOSPHINIC ACID 审中-公开
标题翻译：组合物和剂型为3-氨基 - 正丁基次膦改善的吸收

公开(公告)号：EP1677758A1

公开(公告)日：2006-07-12

申请号：EP04810119.0

申请日：2004-10-29

申请人： ALZA CORPORATION

发明人： WONG, Patrick, S., L. , YAN, Dong , LAM, Andrew , HWANG, Stephen , GUITTARD, George, V.

IPC分类号： A61K9/00 , A61K9/20 , A61K31/185 , A61K31/66 , A61P25/08

CPC分类号： A61K31/662 , A61K9/0004 , A61K31/155 , A61K31/185 , A61K31/195 , A61K31/197 , A61K31/198 , A61K31/20 , A61K31/295 , A61K31/66 , A61K33/26 , A61K47/541 , A61K47/585 , A61K2300/00

摘要： Disclosed are substances, compositions, dosage forms and methods relating to drugs including 3-aminopropyl-n-butyl-phosphinic acid; structural homologs thereof; 3-aminopropyl-n-butyl-phosphinic acid complexes; complexes that comprise structural homologs of 3-aminopropyl-n-butyl-phosphinic acid; pharmaceutically acceptable salts of 3-aminopropyl-n-butyl-phosphinic acid or structural homologs thereof; and mixtures of the above.

2.

发明公开
ONCE-A-DAY, ORAL, CONTROLLED-RELEASE, OXYCODONE DOSAGE FORMS 审中-公开
标题翻译：每日一次口服羟考酮的剂量控释

公开(公告)号：EP1677798A2

公开(公告)日：2006-07-12

申请号：EP04817492.4

申请日：2004-10-28

申请人： ALZA CORPORATION

发明人： HWANG, Stephen , MODI, Nishit, B. , SHIVANAND, Padmaja

IPC分类号： A61K31/485

CPC分类号： A61K31/485 , A61K9/0004 , A61K2300/00

摘要： Oxycodone formulations are provided which produce substantially flat in vivo steady state plasma profiles. Tolerance levels associated with such profiles and tolerance levels associated with biphasic profiles are shown not to be statistically different. The substantially flat in vivo steady state plasma profiles are produced by dosage forms having substantially zero order in vitro release profiles. Such release profiles produce low single dose in vivo Cmax levels which can reduce the probability of adverse side effects.

3.

发明公开
ADMINISTRATION OF LEVODOPA AND CARBIDOPA 审中-公开
标题翻译：左旋多巴和卡比多巴的管理

公开(公告)号：EP1677756A2

公开(公告)日：2006-07-12

申请号：EP04810117.4

申请日：2004-10-29

申请人： ALZA CORPORATION

发明人： WONG, Patrick, S., L. , YAN, Dong , HWANG, Stephen , GUITTARD, George, V.

IPC分类号： A61K9/00 , A61K9/20 , A61K31/198 , A61K31/20 , A61P3/10 , C07C229/34

CPC分类号： A61K31/662 , A61K9/0004 , A61K31/155 , A61K31/185 , A61K31/195 , A61K31/197 , A61K31/198 , A61K31/20 , A61K31/295 , A61K31/66 , A61K33/26 , A61K47/541 , A61K47/585 , A61K2300/00

摘要： Disclosed are substances, compositions, dosage forms and methods that comprise levodopa and/or carbidopa.